Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2007

01-05-2007 | Review Paper

Fibromyxoma of the Small Bowel: A Review

Authors: Meenakshi Chaku, Ehab Elakkary, Fabiana El Sarraf, Thanh Phan

Published in: Digestive Diseases and Sciences | Issue 5/2007

Login to get access

Excerpt

Fibromyxoid describes a rare tumor composed of mature fibroblasts and connective tissue originating from the embryonic tissue of the mesoderm. Cases of gastric fibromyxoma have been reported in the literature, often accompanied by symptoms of dyspepsia and anemia as a result of ulceration of the overlying mucosa [1]. Often the most common nonepithelial tumors found in the gastrointestinal tract are smooth muscle tumors, called gastrointestinal stromal tumors. The stomach and small intestine are the most common locations for these tumors [2]. Because of the rarity of this tumor and its limited reporting in the literature, it is important to recognize this as a distinct entity that must be included in the differential diagnosis when considering a tumor with these characteristics in the small bowel. …
Literature
1.
go back to reference Fukunaga M (2004) Gastric fibromyxoma, a distinct entity of pure fibroblastic tumor—An ultrastructural study. APMIS 112:304–308PubMedCrossRef Fukunaga M (2004) Gastric fibromyxoma, a distinct entity of pure fibroblastic tumor—An ultrastructural study. APMIS 112:304–308PubMedCrossRef
2.
go back to reference Blair SL, Al-Refaie WB, Wang-Rodriguez J, Behling C, Ali MW, Moossa AR (2005) Gastrointestinal stromal tumors express ras oncogene: A potential role for diagnosis and treatment. Arch Surg 140:543–547PubMedCrossRef Blair SL, Al-Refaie WB, Wang-Rodriguez J, Behling C, Ali MW, Moossa AR (2005) Gastrointestinal stromal tumors express ras oncogene: A potential role for diagnosis and treatment. Arch Surg 140:543–547PubMedCrossRef
3.
go back to reference Lin SC, Huang MJ, Zeng CY, Wang TI, Liu ZL, Shiay RK (2003) Clinical manifestations and prognostic factors in patients with gastrointestinal stromal tumors. World J Gastroenterol 9:2809–2812PubMed Lin SC, Huang MJ, Zeng CY, Wang TI, Liu ZL, Shiay RK (2003) Clinical manifestations and prognostic factors in patients with gastrointestinal stromal tumors. World J Gastroenterol 9:2809–2812PubMed
4.
go back to reference DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 231:51–58PubMedCrossRef DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 231:51–58PubMedCrossRef
5.
go back to reference Pierie JP, Choudry U, Muzikansky A, Yeap BY, Souba WW, Ott MJ (2001) The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 136:383–389PubMedCrossRef Pierie JP, Choudry U, Muzikansky A, Yeap BY, Souba WW, Ott MJ (2001) The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 136:383–389PubMedCrossRef
6.
go back to reference Billings SD, Giblen G, Fanburg-Smith JC (2005) Superficial low-grade fibromyxoid sarcoma (Evans tumor): a clinicopathologic analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol 29:204–210PubMedCrossRef Billings SD, Giblen G, Fanburg-Smith JC (2005) Superficial low-grade fibromyxoid sarcoma (Evans tumor): a clinicopathologic analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol 29:204–210PubMedCrossRef
7.
go back to reference Reid R, de Silva MV, Paterson L, Ryan E, Wisher C (2003) Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16)(q34;p11) translocation. Am J Surg Pathol 27:1229–1236PubMedCrossRef Reid R, de Silva MV, Paterson L, Ryan E, Wisher C (2003) Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16)(q34;p11) translocation. Am J Surg Pathol 27:1229–1236PubMedCrossRef
8.
go back to reference Antonescu CR, Baren A (2004) Spectrum of low-grade fibrosarcomas: a comparative ultrastructural analysis of low-grade myxofibrosarcoma and fibromyxoid sarcoma. Ultrastruct Pathol 28:321–332PubMedCrossRef Antonescu CR, Baren A (2004) Spectrum of low-grade fibrosarcomas: a comparative ultrastructural analysis of low-grade myxofibrosarcoma and fibromyxoid sarcoma. Ultrastruct Pathol 28:321–332PubMedCrossRef
9.
go back to reference Iida A, Imamura Y, Katayama K, Hirose K, Yamaguchi A (2003) Plexiform schwannoma of the small intestine: report of a case. Surg Today 33:940–943PubMedCrossRef Iida A, Imamura Y, Katayama K, Hirose K, Yamaguchi A (2003) Plexiform schwannoma of the small intestine: report of a case. Surg Today 33:940–943PubMedCrossRef
10.
go back to reference Coffin CM, Dehner LP, Meis-Kindblom JM (1998) Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: An historical review with differential diagnostic considerations. Semin Diagn Pathol 15:102–110PubMed Coffin CM, Dehner LP, Meis-Kindblom JM (1998) Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: An historical review with differential diagnostic considerations. Semin Diagn Pathol 15:102–110PubMed
11.
go back to reference Ro JY, el-Naggar AK, Amin MB, Sahin AA, Ordonez NG, Ayala AG (1993) Pseudosarcomatous fibromyxoid tumor of the urinary bladder and prostate: immunohistochemical, ultrastructural, and DNA flow cytometric analyses of nine cases. Hum Pathol 24:1203–1210PubMedCrossRef Ro JY, el-Naggar AK, Amin MB, Sahin AA, Ordonez NG, Ayala AG (1993) Pseudosarcomatous fibromyxoid tumor of the urinary bladder and prostate: immunohistochemical, ultrastructural, and DNA flow cytometric analyses of nine cases. Hum Pathol 24:1203–1210PubMedCrossRef
Metadata
Title
Fibromyxoma of the Small Bowel: A Review
Authors
Meenakshi Chaku
Ehab Elakkary
Fabiana El Sarraf
Thanh Phan
Publication date
01-05-2007
Published in
Digestive Diseases and Sciences / Issue 5/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9239-5

Other articles of this Issue 5/2007

Digestive Diseases and Sciences 5/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.